RecruitingNCT03268135

Heart Failure and Aortic Stenosis Transcriptome

Study of the Transcriptomic Alterations in Heart Failure and Aortic Stenosis


Sponsor

IRCCS Policlinico S. Donato

Enrollment

500 participants

Start Date

May 30, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This study is aimed to investigate the global transcriptome in order to determine the expression profile of messenger RNAs (mRNAs), as well as long noncoding- (lncRNAs) and micro noncoding-RNAs (miRNAs) in heart failure (HF) and in aortic stenosis (AS). The aim is to clarify their role in cardiac disease pathogenesis, as well as their potential as biomarkers. To this purpose, both tissue and blood specimens will be collected and patients will be compared to individuals not affected by cardiovascular diseases.


Eligibility

Min Age: 40 YearsMax Age: 75 Years

Inclusion Criteria15

  • Non end-stage heart failure
  • left ventricle restoration surgery (SVR)
  • End Systolic Volume Index (ESVI) \>35 ml/m2
  • Ejection Fraction (EF)\<40%
  • previous transmural anterior myocardial infarction (MI)
  • age: 40-75
  • End-stage heart failure
  • left ventricle assisted device (LVAD) surgery
  • age: 40-75
  • Ejection Fraction (EF) \<25%
  • End Systolic Volume Index (ESVI)≥60 ml/m2
  • Aortic Stenosis
  • aortic valve replacement
  • intracardial pressure difference \>40 mmHg
  • septal diameter ≥1.3 cm

Exclusion Criteria33

  • Non end-stage heart failure
  • End Systolic Volume Index (ESVI)\<35 ml/m2
  • Ejection Fraction (EF)\>40%
  • Time from MI unknown
  • Pregnancy
  • Other genetic diseases
  • Neoplasms
  • Collagenopathies
  • Chemo/radiotherapy
  • Prolonged use of corticosteroids
  • Infections
  • Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) (not vaccination) and Hepatitis C Virus (HCV) positive
  • End-stage heart failure
  • EF\>25%
  • Time from MI unknown
  • Pregnancy
  • Other genetic diseases
  • Neoplasms
  • Collagenopathies
  • Chemo/radiotherapy
  • Prolonged use of corticosteroids
  • Infections
  • Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) (not vaccination) and Hepatitis C Virus (HCV) positive
  • Aortic Stenosis
  • coronaropathies
  • Pregnancy
  • Other genetic diseases
  • Neoplasms
  • Collagenopathies
  • Chemo/radiotherapy
  • Prolonged use of corticosteroids
  • Infections
  • Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) (not vaccination) and Hepatitis C Virus (HCV) positive

Interventions

DIAGNOSTIC_TESTmeasurement of RNAs

Locations(2)

Irccs Policlinico San Donato

San Donato Milanese, Milan, Italy

Ospedale San Raffaele

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03268135


Related Trials